Skip to main content
Signal8

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

$VSEEPress releaseJun 22, 2026, 8:30 AM ETRead the release

VSee Health provided a business update following the May 31 sale of VSee Lab, reporting pro-forma revenue growth of 60% to $8 million in 2025 and 70% to $2.5 million in Q1 2026. The company expects to reduce annual operating expenses by approximately $6.0 million as it refocuses on its iDoc telehealth platform and enterprise solutions.

Key figures

Guidance
$20 million revenue and profitability over the next 12 months
Revenue 2025
8000000
Revenue q1 2026
2500000
Annual opex reduction
6000000

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.